CytoMed Therapeutics Limited (GDTC)

CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $23.08 million. The enterprise value is $20.76 million.

Market Cap	23.08M
Enterprise Value	20.76M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

GDTC has 11.54 million shares outstanding.

Current Share Class	11.54M
Shares Outstanding	11.54M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	17.21%
Owned by Institutions (%)	0.40%
Float	3.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.46
Forward PS	85.29
PB Ratio	4.03
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	36.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.07.

Current Ratio	5.81
Quick Ratio	4.31
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-169.20

Financial Efficiency

Return on equity (ROE) is -42.33% and return on invested capital (ROIC) is -24.06%.

Return on Equity (ROE)	-42.33%
Return on Assets (ROA)	-22.85%
Return on Invested Capital (ROIC)	-24.06%
Return on Capital Employed (ROCE)	-46.02%
Revenue Per Employee	$13,330
Profits Per Employee	-$67,065
Employee Count	43
Asset Turnover	0.08
Inventory Turnover	0.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.91% in the last 52 weeks. The beta is -0.35, so GDTC's price volatility has been lower than the market average.

Beta (5Y)	-0.35
52-Week Price Change	-9.91%
50-Day Moving Average	2.11
200-Day Moving Average	2.24
Relative Strength Index (RSI)	43.19
Average Volume (20 Days)	190,370

Short Selling Information

The latest short interest is 16,818, so 0.15% of the outstanding shares have been sold short.

Short Interest	16,818
Short Previous Month	103,710
Short % of Shares Out	0.15%
Short % of Float	0.46%
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, GDTC had revenue of $573,193 and -$2.88 million in losses. Loss per share was -$0.25.

Revenue	573,193
Gross Profit	530,297
Operating Income	-2.77M
Pretax Income	-2.89M
Net Income	-2.88M
EBITDA	-2.50M
EBIT	-2.77M
Loss Per Share	-$0.25

Balance Sheet

The company has $2.24 million in cash and $384,501 in debt, giving a net cash position of $1.86 million or $0.16 per share.

Cash & Cash Equivalents	2.24M
Total Debt	384,501
Net Cash	1.86M
Net Cash Per Share	$0.16
Equity (Book Value)	5.67M
Book Value Per Share	0.49
Working Capital	2.65M

Cash Flow

In the last 12 months, operating cash flow was -$2.48 million and capital expenditures -$658,035, giving a free cash flow of -$3.08 million.

Operating Cash Flow	-2.48M
Capital Expenditures	-658,035
Free Cash Flow	-3.08M
FCF Per Share	-$0.27

Margins

Gross Margin	92.52%
Operating Margin	-482.59%
Pretax Margin	-504.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.75%
FCF Yield	-13.60%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GDTC has an Altman Z-Score of 14.7 and a Piotroski F-Score of 3.

Altman Z-Score	14.7
Piotroski F-Score	3